Literature DB >> 26181524

Prescribing to fit the needs of older people--the NHS Scotland Polypharmacy Guidance, 2nd edition.

M Wilson1, A Mair, T Dreischulte, M D Witham.   

Abstract

Entities:  

Keywords:  guidelines; mulimorbidity; polypharmacy; prescribing

Mesh：

Year:  2015        PMID： 26181524     DOI： 10.4997/JRCPE.2015.204

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN： 1478-2715


× No keyword cloud information.
  12 in total

1.  Applicability of the STOPP/START criteria to older polypathological patients in a long-term care hospital.

Authors:  Julia Hernandez Martin; Virginia Merino-Sanjuán; Juan Peris-Martí; Marta Correa-Ballester; Raquel Vial-Escolano; Matilde Merino-Sanjuán
Journal:  Eur J Hosp Pharm       Date:  2017-08-09

2.  Polypharmacy and emergency readmission to hospital after critical illness: a population-level cohort study.

Authors:  Angus J Turnbull; Eddie Donaghy; Lisa Salisbury; Pamela Ramsay; Janice Rattray; Timothy Walsh; Nazir Lone
Journal:  Br J Anaesth       Date:  2020-10-31       Impact factor: 9.166

3.  Costs of medication in older patients: before and after comprehensive geriatric assessment.

Authors:  Gulcin Done Unutmaz; Pinar Soysal; Busra Tuven; Ahmet Turan Isik
Journal:  Clin Interv Aging       Date:  2018-04-09       Impact factor: 4.458

4.  Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.

Authors:  Enrica Menditto; Antonio Gimeno Miguel; Aida Moreno Juste; Beatriz Poblador Plou; Mercedes Aza Pascual-Salcedo; Valentina Orlando; Francisca González Rubio; Alexandra Prados Torres
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

5.  Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.

Authors:  Joanna Ulley; Deborah Harrop; Ali Ali; Sarah Alton; Sally Fowler Davis
Journal:  BMC Geriatr       Date:  2019-01-18       Impact factor: 3.921

6.  Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens.

Authors:  Przemysław Kardas; Filip Urbański; Aneta Lichwierowicz; Ewa Chudzyńska; Grzegorz Kardas; Marcin Czech
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

7.  GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial.

Authors:  Caroline McCarthy; Barbara Clyne; Fiona Boland; Frank Moriarty; Michelle Flood; Emma Wallace; Susan M Smith
Journal:  PLoS Med       Date:  2022-01-05       Impact factor: 11.069

Review 8.  Optimising prescribing practices in older adults with multimorbidity: a scoping review of guidelines.

Authors:  Penny Lun; Felicia Law; Esther Ho; Keng Teng Tan; Wendy Ang; Yasmin Munro; Yew Yoong Ding
Journal:  BMJ Open       Date:  2021-12-14       Impact factor: 2.692

9.  Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.

Authors:  Peter Hanlon; Barbara I Nicholl; Bhautesh Dinesh Jani; Ross McQueenie; Duncan Lee; Katie I Gallacher; Frances S Mair
Journal:  BMJ Open       Date:  2018-01-14       Impact factor: 2.692

10.  Variation of polypharmacy in older primary care attenders occurs at prescriber level.

Authors:  Su Miin Ong; Yvonne Mei Fong Lim; Sheamini Sivasampu; Ee Ming Khoo
Journal:  BMC Geriatr       Date:  2018-02-23       Impact factor: 3.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.